FDA Approved: LEVOXYL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved a supplemental application for LEVOXYL (levothyroxine sodium) submitted by Pfizer Laboratories Div Pfizer Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Goiter
• Hypothyroidism

Drugs mentioned

• LEVOXYL (LEVOTHYROXINE SODIUM)

Snippet

SUPPL AP for LEVOXYL (LEVOTHYROXINE SODIUM)